Penicillin antibiotics are first line for many infections in hospitalized patients. They’re effective, often have a narrower antibiotic spectrum of action, are well-tolerated, and often more cost-effective compared to alternatives like quinolones or glycopeptides.
However, around 15% of hospitalized patients have a “penicillin allergy” label in their medical records, which means they’re denied first-line therapy. But here’s the thing: studies show that up to 95% of these patients could safely tolerate penicillin after allergy testing. That means a significant number of patients are missing out on the best treatment option due to an inaccurate label.
Delabelling, or removing the penicillin allergy label for those who don’t truly have an allergy, has several benefits:
Who should take this course?
This course is designed for healthcare workers who want to gain the knowledge and skills to confidently identify low-risk penicillin allergy records and discuss delabeling with patients.
What participants can expect:
By upskilling healthcare workers to safely assess penicillin allergy records, we can: